IN2013MN00513A - - Google Patents

Download PDF

Info

Publication number
IN2013MN00513A
IN2013MN00513A IN513MUN2013A IN2013MN00513A IN 2013MN00513 A IN2013MN00513 A IN 2013MN00513A IN 513MUN2013 A IN513MUN2013 A IN 513MUN2013A IN 2013MN00513 A IN2013MN00513 A IN 2013MN00513A
Authority
IN
India
Prior art keywords
monoclonal antibody
antigen
fragment
bonded
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Shuji Sato
Takeshi Goto
Shigeru Goto
Toshiaki Nakano
Naoya Ohmori
Kueichen Chiang
Yayoi Shimada
Kenji Mori
Takamitsu Miyagi
Original Assignee
Josai University Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Josai University Corp filed Critical Josai University Corp
Publication of IN2013MN00513A publication Critical patent/IN2013MN00513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN513MUN2013 2010-08-20 2011-08-19 IN2013MN00513A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010185406 2010-08-20
PCT/JP2011/068793 WO2012023614A1 (ja) 2010-08-20 2011-08-19 免疫抑制活性を有するモノクローナル抗体またはその抗原結合断片

Publications (1)

Publication Number Publication Date
IN2013MN00513A true IN2013MN00513A (enrdf_load_stackoverflow) 2015-06-12

Family

ID=45605266

Family Applications (1)

Application Number Title Priority Date Filing Date
IN513MUN2013 IN2013MN00513A (enrdf_load_stackoverflow) 2010-08-20 2011-08-19

Country Status (9)

Country Link
US (1) US9701739B2 (enrdf_load_stackoverflow)
EP (1) EP2631246B1 (enrdf_load_stackoverflow)
JP (1) JP5960596B2 (enrdf_load_stackoverflow)
KR (1) KR101863978B1 (enrdf_load_stackoverflow)
CN (1) CN103534271B (enrdf_load_stackoverflow)
IN (1) IN2013MN00513A (enrdf_load_stackoverflow)
RU (1) RU2559550C2 (enrdf_load_stackoverflow)
TW (1) TWI449710B (enrdf_load_stackoverflow)
WO (1) WO2012023614A1 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103534271B (zh) 2010-08-20 2016-06-22 学校法人城西大学 有免疫抑制活性的单克隆抗体或其抗原结合片段
SI2731677T1 (sl) 2011-07-11 2018-09-28 Glenmark Pharmaceuticals S.A. Protitelesa, ki se vežejo na OX40 in njihove uporabe
JP2015117181A (ja) * 2012-02-22 2015-06-25 学校法人 城西大学 敗血症治療剤
CA2898472C (en) * 2013-02-15 2023-03-07 Immunomedics, Inc. Chimeric and humanized anti-histone antibodies
JPWO2013125687A1 (ja) * 2013-02-22 2015-07-30 学校法人 城西大学 炎症疾患治療剤
CN105850770A (zh) * 2016-05-16 2016-08-17 贾文龙 一种宠物接便器

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0572443A1 (en) * 1990-12-17 1993-12-08 The Johns Hopkins University Suppression of immune responses with oligomeric forms of antigen of controlled chemistry
JP2004014950A (ja) 2002-06-10 2004-01-15 Nippon Tungsten Co Ltd Ｐｔｃ特性を有するセラミックス材料
US20040052780A1 (en) 2002-09-05 2004-03-18 Hisamitsu Pharmaceutical Co., Inc. Immunosuppresants
JP2004149507A (ja) 2002-09-05 2004-05-27 Hisamitsu Pharmaceut Co Inc 免疫抑制剤
KR20070073754A (ko) 2004-09-03 2007-07-10 아마테라스파마 가부시키가이샤 항-히스톤 ｈ1 모노크로날 항체 및 그것을 생성할 수 있는하이브리도마
JPWO2009001673A1 (ja) 2007-06-26 2010-08-26 学校法人 城西大学 Ａｔｐ含有免疫アジュバント
JPWO2009004900A1 (ja) * 2007-06-29 2010-08-26 学校法人 城西大学 ユビキノン含有免疫アジュバント
US20100324469A1 (en) 2007-10-04 2010-12-23 Josai University Corporation Drug product, a method of administrating a vaccine using the drug product, and an apparatus for iontophoresis
WO2009061918A1 (en) 2007-11-06 2009-05-14 Oklahoma Medical Research Foundation Extracellular histones as biomarkers for prognosis and molecular targets for therapy
CN103534271B (zh) 2010-08-20 2016-06-22 学校法人城西大学 有免疫抑制活性的单克隆抗体或其抗原结合片段
SI2731677T1 (sl) * 2011-07-11 2018-09-28 Glenmark Pharmaceuticals S.A. Protitelesa, ki se vežejo na OX40 in njihove uporabe
JP2015117181A (ja) 2012-02-22 2015-06-25 学校法人 城西大学 敗血症治療剤

Also Published As

Publication number Publication date
TWI449710B (zh) 2014-08-21
KR101863978B1 (ko) 2018-06-01
WO2012023614A1 (ja) 2012-02-23
KR20130137612A (ko) 2013-12-17
US9701739B2 (en) 2017-07-11
CN103534271B (zh) 2016-06-22
TW201300416A (zh) 2013-01-01
JPWO2012023614A1 (ja) 2013-12-12
JP5960596B2 (ja) 2016-08-02
RU2013112324A (ru) 2014-09-27
EP2631246A1 (en) 2013-08-28
US20140010815A1 (en) 2014-01-09
EP2631246A4 (en) 2014-01-15
CN103534271A (zh) 2014-01-22
RU2559550C2 (ru) 2015-08-10
EP2631246B1 (en) 2016-07-20

Similar Documents

Publication Publication Date Title
NZ610267A (en) A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
WO2013059885A3 (en) Polypeptide constructs and uses thereof
NZ597692A (en) Anti-IGF antibodies
IN2013MN00513A (enrdf_load_stackoverflow)
NZ607969A (en) Cd33 binding agents
RU2018132044A (ru) Антитела против тау
MX351682B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2010004660A (es) NUEVOS ANTICUERPOS ESPECIFICOS DE LOS PEPTIDOS ß-AMILOIDES Y SUS USOS COMO AGENTES DE DIAGNOSTICO Y DROGAS.
WO2012051498A3 (en) Antibodies that bind amyloid oligomers
NZ703653A (en) Anti-fap antibodies and methods of use
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
NZ612312A (en) Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
WO2010129895A3 (en) Cd133 epitopes
MX341309B (es) Anticuerpos especificos del heterodimero de anti-il-23.
MX2011008759A (es) Medios y metodos para fabricar neurotoxina altamente pura.
WO2012091564A3 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding mhc-mage complex that induces apoptosis
WO2012047732A3 (en) Antibody compositions and methods of use
MX2015007421A (es) Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas.
EA201270701A1 (ru) Ингибирующие металлопротеины антитела
NZ607615A (en) Antibodies directed against il-17
MY166152A (en) Anti-human xcr1 antibodies
WO2010011952A3 (en) Flip death effector domain derived peptides for inducing autophagy
IN2014DN07875A (enrdf_load_stackoverflow)
IN2014DN09367A (enrdf_load_stackoverflow)
WO2010127180A3 (en) Dc-stamp antibodies